HopeStage
Back to all studies
Not Yet RecruitingNCT07553377

A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease

Device studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: October 2027
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
50
Sponsor
Yale University
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07553377
Official title
Show the full official title

A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease

Recruitment & locations

Not yet recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies